Eric C M van Gorp Selected Research

Eric C M van Gorp Research Topics

Disease

22	Infections 12/2021 - 01/2002
9	Dengue (Dengue Fever) 11/2022 - 05/2003
8	Virus Diseases (Viral Diseases) 01/2022 - 01/2002
7	Severe Dengue 01/2019 - 01/2002
5	Human Influenza (Influenza) 08/2020 - 11/2006
5	Fever (Fevers) 04/2016 - 01/2009
4	COVID-19 01/2022 - 01/2021
4	Bacterial Infections (Bacterial Infection) 07/2016 - 08/2005
3	Leptospirosis 01/2013 - 06/2009
2	Hepatitis 11/2022 - 10/2003
2	Yellow Fever 11/2022 - 01/2011
2	Thrombocytopenia (Thrombopenia) 10/2022 - 10/2014
2	Critical Illness (Critically Ill) 01/2022 - 08/2005
2	Thrombosis (Thrombus) 01/2022 - 01/2015
2	Zika Virus Infection 12/2021 - 01/2019
2	Communicable Diseases (Infectious Diseases) 01/2020 - 03/2002
2	Inflammation (Inflammations) 01/2013 - 04/2010
2	Myocardial Infarction 04/2010 - 03/2003
1	Venous Thrombosis (Deep-Vein Thrombosis) 10/2022
1	Severe Acute Respiratory Syndrome 01/2022
1	Pneumococcal Infections 01/2022
1	Measles 11/2021
1	HIV Infections (HIV Infection) 01/2021
1	Chronic Disease (Chronic Diseases) 01/2021
1	Crohn Disease (Crohn's Disease) 08/2020
1	Cytokine Release Syndrome 01/2020
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2020
1	Hypophysitis 10/2019
1	Disease Progression 02/2019
1	Respiratory Tract Infections (Respiratory Tract Infection) 07/2016
1	Hemorrhage 10/2015
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 08/2015
1	Insulin Resistance 08/2015
1	Hypertension (High Blood Pressure) 08/2015
1	Hypersensitivity (Allergy) 08/2015
1	Hantavirus Infections 01/2015
1	Lung Abscess 11/2012
1	Takayasu Arteritis (Arteritis, Takayasu's) 11/2012
1	Tick-Borne Encephalitis (Encephalitis, Tick Borne) 01/2011
1	Japanese Encephalitis 01/2011
1	Cardiovascular Diseases (Cardiovascular Disease) 04/2010

Drug/Important Bio-Agent (IBA)

10	Biomarkers (Surrogate Marker)IBA 01/2022 - 02/2010
10	AntibodiesIBA 01/2022 - 03/2003
5	CytokinesIBA 06/2009 - 01/2002
4	VaccinesIBA 11/2022 - 12/2014
4	FibrinIBA 01/2022 - 11/2006
4	Interleukin-6 (Interleukin 6)IBA 01/2020 - 01/2002
4	ProcalcitoninIBA 07/2016 - 02/2010
4	Anti-Bacterial Agents (Antibiotics)IBA 07/2016 - 02/2005
4	von Willebrand FactorIBA 01/2015 - 04/2010
4	C-Reactive ProteinIBA 04/2010 - 08/2005
4	Nevirapine (Viramune)FDA Link 10/2003 - 10/2002
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 04/2010
3	Immunoglobulin G (IgG)IBA 12/2021 - 03/2003
3	Thrombin FDA Link 01/2015 - 11/2006
3	LipopolysaccharidesIBA 01/2015 - 01/2012
3	EnzymesIBA 10/2014 - 10/2002
3	fibrin fragment D (D-dimer)IBA 05/2014 - 01/2002
2	Neutralizing AntibodiesIBA 01/2022 - 11/2021
2	Antiviral Agents (Antivirals)IBA 01/2020 - 04/2008
2	Hemostatics (Antihemorrhagics)IBA 01/2015 - 05/2014
2	Plasminogen InactivatorsIBA 01/2015 - 11/2006
2	Lipopolysaccharide ReceptorsIBA 01/2015 - 01/2013
2	Protein CIBA 04/2010 - 11/2006
2	BilirubinIBA 04/2009 - 10/2002
2	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 07/2003 - 01/2002
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2003 - 01/2002
2	Interleukin-1beta (Interleukin 1 beta)IBA 07/2003 - 01/2002
2	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 07/2003 - 01/2002
1	COVID-19 VaccinesIBA 01/2022
1	2019-nCoV Vaccine mRNA-1273IBA 01/2022
1	Viral RNAIBA 11/2021
1	Interleukin-12 (IL 12)IBA 08/2020
1	Adalimumab (Humira)FDA Link 08/2020
1	Ustekinumab (CNTO 1275)FDA Link 08/2020
1	Inactivated VaccinesIBA 01/2020
1	Interleukin-10 (Interleukin 10)IBA 01/2020
1	Hormones (Hormone)IBA 08/2015
1	Hydrocortisone (Cortisol)FDA LinkGeneric 08/2015
1	lipopolysaccharide-binding proteinIBA 01/2015
1	AntigensIBA 01/2015
1	CoagulantsIBA 01/2015
1	Thromboplastin (Tissue Factor)IBA 01/2015
1	Ferritins (Ferritin)IBA 10/2014
1	Interleukin-18 (Interleukin 18)IBA 10/2014
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 08/2014
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 08/2014
1	Angiopoietin-2IBA 08/2014
1	cytidylyl-(3'-5')-cytidine (CpC)IBA 01/2013
1	tocilizumab (atlizumab)FDA Link 11/2012
1	abacavir (Ziagen)FDA Link 04/2010
1	Fibrinogen (Factor I)FDA Link 04/2010
1	Prothrombin (Factor II)IBA 04/2010
1	Factor VIII (Coagulation Factor VIII)IBA 04/2010
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2010

Therapy/Procedure

7	Therapeutics 11/2022 - 02/2005
4	Length of Stay 01/2021 - 02/2010
1	Highly Active Antiretroviral Therapy (HAART) 01/2021
1	Artificial Respiration (Mechanical Ventilation) 01/2020
1	Injections 12/2014